title: Drug-induced QT prolongation.
authors.affiliation: Department of Internal Medicine A, Assaf Harofeh Medical Center, Zerifin, Israel.
authors.forename: M K
authors.initials: MK
authors.lastname: Michowitz
authors.forename: Y
authors.initials: Y
authors.lastname: Michowitz
authors.forename: R
authors.initials: R
authors.lastname: Zaidenstien
authors.forename: A
authors.initials: A
authors.lastname: Golik
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D004562:Electrocardiography; D005260:Female; D006634:Histamine H1 Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000175:diagnosis*; D008297:Male; D011379:Prognosis; D018570:Risk Assessment
chemical_list: D000889:Anti-Arrhythmia Agents; D000900:Anti-Bacterial Agents; D014150:Antipsychotic Agents; D006634:Histamine H1 Antagonists